(NASDAQ:AMTX) shares saw light trading volume with 10K shares changing hands by the end of trading on Tuesday. Overall, volume was down 83.32% under the stocks normal daily volume.
Traders are a little more bullish on Aemetis Inc Cmn Stk of late considering the fall in short interest. The stock had a fall in short interest of -12.96% as of the latest report on October 13, 2017. Short shares fell from 134,537 to 117,105 over that period. The days to cover increased to 11.0 and the percentage of shorted shares is 0.01% as of October 13.
Here are a few substantial investment firms who have updated their positions. Blackrock Inc. downsized its ownership by shedding 4,333 shares a decrease of 53.4% as of 06/30/2017. Blackrock Inc. owns 3,787 shares worth $5,000. The total value of its holdings decreased 50.0%. As of the end of the quarter Citadel Advisors LLC had acquired a total of 3,685 shares growing its stake by 32.7%. The value of the total investment in Aemetis Inc Cmn Stk increased from $13,000 to $20,000 a change of 53.8% since the last quarter.
As of quarter end Ubs Group Ag had bought 337 shares growing its position 9.8%. The value of the investment in AMTX went from $4,000 to $5,000 increasing 25.0% quarter over quarter. Nwam LLC grew its holdings by buying 25 shares an increase of 0.0%. Nwam LLC currently owns 53,077 shares with a value of $46,000. The value of the position overall is down by 35.2%.
August 19 investment analysts at FBR & Co maintained a stock rating of “Neutral” with a current price target of $2.00.
The company is down by 4.11% since yesterday’s close of 0.73. The P/E ratio is currently N/A and the market cap is 13.88M. In the last earnings report the EPS was $-1.01 with 19.82M shares outstanding.
Aemetis, Inc., launched on October 24, 2006, is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. The Business’s segments include North America and India. The North America segment includes the Business’s 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Business’s over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius..